Taking people in Franciaország1. fázis
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid Tumours
Key facts
- Where
- Bordeaux, Lille Cedex, Lyon Cedex 08, Marseille, Nice Cedex 2, Rennes és Villejuif, FranciaországSee the 7 sites
- Phase
- 1. fázis
Where in Franciaország
- Institut BergonieBordeaux, FranciaországTaking people
- Institut Coeur Poumon - CHU LilleLille Cedex, FranciaországTaking people
- Centre Léon BérardLyon Cedex 08, FranciaországTaking people
- Hôpitaux Universitaires de Marseille TimoneMarseille, FranciaországTaking people
- Centre Antoine LacassagneNice Cedex 2, FranciaországTaking people
- Centre Hospitalier Universitaire de RennesRennes, FranciaországTaking people
- Institut Gustave RoussyVillejuif, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Deuteroncology
- Trial code
- EU 2023-504897-39-00
- Record updated
- 2026. augusztus 12.